Cancer Risk and subsequent survival after hospitalization for intermittent claudication

Cancer Epidemiology Biomarkers and Prevention

Volumn 24, Issue 4, 2015, Pages 744-748

  Onega, Tracy ^a,b   Baron, John A ^c,d   Johnsen, Søren P ^d   Pedersen, Lars ^d   Farkas, Dóra K ^d   Sørensen, Henrik T ^d  

^a DARTMOUTH MEDICAL SCHOOL   (United States)

^b NORRIS COTTON CANCER CENTER   (United States)

^c UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^d AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BLADDER CANCER; CANCER DIAGNOSIS; CANCER INCIDENCE; CANCER LOCALIZATION; CANCER PATIENT; CANCER REGISTRY; CANCER RISK; CANCER STAGING; CANCER SURVIVAL; CEREBROVASCULAR DISEASE; COHORT ANALYSIS; CONTROLLED STUDY; DENMARK; DIABETES MELLITUS; ESOPHAGUS CANCER; FEMALE; FOLLOW UP; HEART INFARCTION; HODGKIN DISEASE; HOSPITALIZATION; HUMAN; INTERMITTENT CLAUDICATION; KIDNEY CANCER; LARYNX CANCER; LEUKEMIA; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; NONHODGKIN LYMPHOMA; PANCREAS CANCER; PRIORITY JOURNAL; STANDARDIZED INCIDENCE RATIO; TOBACCO; TONGUE CANCER; ADOLESCENT; CHILD; INFANT; MIDDLE AGED; NEOPLASMS; NEWBORN; PRESCHOOL CHILD; REGISTER; RISK FACTOR; STATISTICS AND NUMERICAL DATA; SURVIVAL RATE; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; FEMALE; HOSPITALIZATION; HUMANS; INFANT; INFANT, NEWBORN; INTERMITTENT CLAUDICATION; MALE; MIDDLE AGED; NEOPLASMS; REGISTRIES; RISK FACTORS; SURVIVAL RATE; YOUNG ADULT;

EID: 84927918813     PISSN: 10559965     EISSN: 15387755     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-14-1255     Document Type: Article

References (23)

1. Faxon DP, Creager MA, Smith SC Jr, Pasternak RC, Olin JW, Bettmann MA, et al. Atheroslcerotic vascular disease conference: executive summary: atherosclerotic vascular disease conference proceeding for healthcare professionals from a special writing group of the American Heart Association. Circulation 2004;109:2595-604.
2. Diehm C, Kareem S, Lawall H. Epidemiology of peripheral arterial disease. Vasa 2004;33:183-9.
3. Garcia LA. Epidemiology and patholophysiology of peripheral arterial disease. J Endovasc Ther 2006;13 (suppl 2):II3-9.
4. Dreyer L, Olsen JH. Cancer risk of patients discharged with acute myocardial infarct. Epidemiology 1998;9:178-83.
5. Dreyer L, Olsen JH. Risk for non-smoking-related cancer in atherosclerotic patients. Cancer Epidemiol Biomarker Prev 1999;8:915-8.
6. Naschitz JE, Kovaleva J, Shaviv N, Rennert G, Yeshurun D. Vascular disorders preceding diagnosis of cancer: distinguishing the causal relationship based on Bradford-Hill guidelines. Angiology 2003;54: 11-7.
7. Naschitz JE, Schechter L, Chang JB. Intermittent claudication associated with cancer-case studies. Angiology 1987;38:696-704.
8. Taute BM, Thommes S, Taute R, Podhaisky H. The possible risk of cancer in claudicants. Angiology 2011;62:579-84.
9. Pehrsson SK, Linnersjo A, Hammar N. Cancer risk of patients with ischaemic syndromes. J Int Med 2005;258:124-32.
10. Reicher-Reiss H, Jonas M, Goldbourt U, Boyko V, Modan B. Selectively increased risk of cancer in men with coronary heart disease. Am J Cardiol 2001;87:459-62.
11. van Kruijsdijk RCM, van derGraaf Y, Peeters PHM, Visseren FLJ. Cancer risk in patients with manifest vascular disease: effects of smoking, obesity, and metabolic syndrome. Cancer Epidemiol Biomarker Prev 2013;22: 1267-77.
12. Schmidt M, Pedersen L, Sørensen HT. The Danish Civil Registration System as a tool in epidemiology. Eur J Epidemiol 2014;29: 541-9.
13. Frank L. Epidemiology. When an entire country is a cohort. Science 2000;287:2398-9.
14. Lynge E, Sandegaard JL, Rebolj M. The Danish National Patient Register. Scand J Public Health 2011;39:30-3.
15. The Ministry of Health. Health care in Denmark [Internet]. Denmark; c2008-13 [cited 2015 Jan 15]. Available from:http://www.sum.dk/Aktuelt/Publikationer/Publikationer/~/media/Filer%20-%20Publikationer-i-pdf/2008/UK-Healthcare-in-dk/pdf.ashx
16. Andersen TF,Madsen M, Jorgensen J, Mellemkjoer L, Olsen JH. The Danish National Hospital Register. A valuable source of data for modern health sciences. Danish Medical Bulletin 1999;46:263-8.
17. Sorensen HT, Mellemkjaer L, Steffensen FH,Olsen JH, Nielsen GL. The risk of diagnosis of cancer after primary deep venous thrombosis or pulmonary embolism. New Engl J Med 1998;338:1169-73.
18. Gjerstorff ML. The danish cancer registry. Scand J Public Health 2011; 39:42-5.
19. Storm HH, Michelsen EV, Clemmensen IH, Pihl J. The Danish Cancer Registry-history, content, quality, and use. Danish Medical Bulletin 1997; 44:535-9.
20. Thygesen SK, Christiansen CF, Christensen S, Lash TL, Sorensen HT. The predictive value of ICD-10 diagnostic coding used to assess Charlson comorbidity index conditions in the population-based Danish National Registry of Patients. BMC Med Res Methodol 2011;11:83.
21. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987;40:373-83.
22. Breslow NE, Day NE. Statistical methods in cancer research. volume II-the design and analysis of cohort studies. Lyon, France: International Agency for Research on Cancer;1987.
23. IARC. Tobacco smoking and tobacco smoke. In: IARC Monographs on the Carcinogenic Risk of Chemicals to Humans,No 83 [Internet]. Lyon, France: IARC, 2002. [cited 2015 Jan 15]. Available at: http://monographs.iarc.fr/ENG/Monographs/vol83/mono83.pdf.